Boston Scientific Corporation To Collaborate With Affinergy, Inc. On Novel Cardiovascular Stent Coatings

Published: Nov 01, 2005

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nov. 1, 2005--Affinergy, Inc., a Duke University spinout with a proprietary site-specific biological delivery system, recently signed a collaboration agreement with Boston Scientific (NYSE: BSX) to investigate new coatings for cardiovascular stents. Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices whose products are used in a broad range of interventional medical specialties.

Back to news